Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114955) titled 'Analysis of Risk Factors for Persistent HR-HPV Infection in HSIL Patients after Cervical LEEP Procedure' on Dec. 19, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The International Peace Maternity and Child Health Hospital
Condition:
Cervical intraepithelial neoplasia grade II, cervical intraepithelial neoplasia grade III, cervical carcinoma in situ, high-risk human papillomavirus (HR-HPV) infection
Intervention:
persistent HR-HPV infection group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-30
Target Sample Size: persistent HR...